Driven by moderate debt load, negative free cash flow, the company is currently loss-making.
In simple words: The company is currently losing money, but sales are shrinking. Cash generation is currently the main factor to watch.
Decision support, not a buy or sell call.
As of 18 Oct 2026, 6:02 pm
Caution warranted. Multiple fundamental metrics — flagged in red below — point to either valuation stretch, leverage risk, or weakening profitability. This doesn't mean avoid the stock outright, but it does mean the burden of proof is on the growth story to justify the current price.
The 60-second version of STL Networks Limited — what it does, how it earns, and who it competes with, before any of the numbers below.
What does this company do?
STL Networks Limited operates as a digital infrastructure and information technology (IT) services company under the Invenia brand in India and the United Kingdom.
IndustryTelecom Services
SectorCommunication Services
Employees412
Annual revenue₹959 Cr
How does it make money?
Turns over ₹959 Cr a year. Of every ₹100 of sales, about ₹-10 reaches shareholders as profit, with ₹7 left at the operating level before interest, tax and depreciation. Each of its 412 employees supports ₹2.33 Cr of revenue a year, the signature of a capital- or asset-led business.
EBITDA margin7.4%
Net margin-10.3%
Revenue / employee₹2.33 Cr
Who are its competitors?
The closest listed comparisons in its industry are BHARTI AIRTEL LIMITED, VODAFONE IDEA LIMITED. These are the companies its valuation and returns are measured against elsewhere in this report.
BHARTI AIRTEL LIMITEDP/E 39.8x · ROE 20.2%
VODAFONE IDEA LIMITEDP/E 3.6x · ROE —
What is its competitive advantage?Little sign of one
Returns on capital of -0.7% are at or below what the capital likely costs. That is the financial pattern of a business competing largely on price, where advantage has to come from execution rather than position.
ROCE-0.7%
ROE-12.4%
Peer median ROE20.2%
What has been driving growth?
Profit has moved mainly because margins changed, not because the business sold much more. Over 1 years revenue moved -19% while net margin moved +281% relative to itself. What this cannot tell you is which products, customers or geographies did the work — that lives in the segment disclosures of the annual report.
Revenue effect-19%
Margin effect+281%
DalalBaazaar Score
25/ 100
Weak
Weighted across six categories. Every point is explained below.
✗ Revenue has contracted at 18.6% a year
✗ Profit fell 210.2% in the latest year
Quality vs. Valuation
Company Quality
24/ 100
Weak
How good the business is, ignoring the share price entirely.
vs
Valuation
25/ 100
Expensive
What you are being asked to pay, ignoring how good the business is.
Weak on business quality and not cheap enough to compensate.
vs. its own history
Not enough price and earnings history
vs. sector peers
Not enough peers with a usable P/E
vs. generic bands
N/A
No P/E — the company is lossmaking
P/E (Trailing)
Not meaningful
P/B
2.62x
EV/EBITDA
41.7x
PEG
—
Dividend Yield
None
What's Good / What's Bad
🟢 What's Going Well1
Margins are improving
EBITDA margin is up from 5.2% to 7.4% over 1 years.
🔴 What Needs Attention4
Free cash flow is negative
The business is not currently covering its capital spending from operations.
Return on equity is falling
ROE has dropped from -3.5% to -12.4% — each rupee of shareholder capital earns less than it did.
Return on capital is falling
ROCE has declined from 4.7% to -0.7% — often a sign of competition or overexpansion.
Inventory building faster than sales
Inventory is up 92% against revenue growth of -19% — stock may not be moving.
Red Flags
5 items require attention · 3 high · 2 watch
🔴Thin interest coverageFinancial
Operating profit covers interest only -0.1x — little room if earnings dip.
🔴The company is lossmakingFinancial
Net profit of -₹99 Cr in the latest reported year.
🔴Inventory building faster than salesFinancial
Inventory up 92% against revenue up -19% — stock may not be moving.
🟡Interest coverage is deterioratingFinancial
Cover has fallen from 0.7x to -0.1x.
🟡Free cash flow is negativeFinancial
Free cash flow was -₹112 Cr in the latest year.
Investment Thesis
🟢 Bull CaseWhat could make this work?
Margin expansion has further to run
EBITDA margin has risen from 5.2% to 7.4%. If that holds, profit compounds faster than sales and today's multiple looks cheaper in hindsight than it does now.
🔴 Bear CaseWhat could go wrong?
The debt load needs earnings to hold up
Debt is 13.2x EBITDA. At that level a downturn in earnings turns a manageable balance sheet into a refinancing problem, and lenders get paid before shareholders.
Returns on shareholder capital are falling
ROE has dropped from -3.5% to -12.4%. Each rupee of equity earns less than it did, so profit growth increasingly depends on raising more capital rather than on the existing base working harder.
Size brings its own risk
Micro Cap businesses are thinly traded, so exits are harder in a falling market and single events move the price more than they would for a larger company.
Several serious flags at once
3 high-severity checks triggered. Individually each has an explanation; together they raise the chance that something structural is wrong rather than a one-off.
🟡 Key Things to WatchMeasurable tripwires, set against where this company stands today
1EBITDA margin holds above 5%✓ 7.4%
Two points below today's level — enough room for noise, tight enough to catch real compression.
2Debt / EBITDA falls below 3x✗ 13.2x
Already stretched, so this is a reduction target rather than a level to hold. Around 3x is where lenders typically start attaching conditions.
3Free cash flow remains positive✗ -₹112 Cr
Profit that never becomes cash eventually stops being profit.
4Interest cover stays above 3x✗ -0.1x
How much operating profit can fall before interest stops being comfortably covered.
5ROCE stays above 8%✗ -0.7%
Falling returns on capital are usually competition arriving, and show up here before they reach the margin.
Investment Checklist
4 / 11 checks passed
✗ Strong return on equity (ROE ≥ 15%)
✗ Strong return on capital employed (ROCE ≥ 15%)
✗ Healthy net margin (≥ 10%)
✗ Generates positive free cash flow
✗ Manageable leverage (Debt/Equity < 1.0)
✓ Adequate short-term liquidity (Current Ratio ≥ 1.0)
✗ Revenue growing year-over-year
✗ Profit growing year-over-year
✓ Not trading at an extreme valuation (P/E < 40x)
✓ Not buying right at the 52-week high
✓ Short-term technical trend isn't bearish
Price history
Quick Metrics
0 good · 4 neutral · 7 weak
Market Cap
₹2,100 Cr
Micro Cap
Smaller company — thin liquidity and deep drawdowns are normal here
P/E (Trailing)
Not meaningful
Loss-making
Earnings are negative, so a P/E multiple can't be read here
P/B Ratio
2.62x
Fair
Moderate premium to the company's book value
EPS (TTM)
₹-2.02
Loss-making
Negative earnings per share — the business is losing money
ROE
-12.4%
Weak
Weak capital efficiency
ROCE
-0.7%
Weak
Low return on total capital employed
Debt/Equity
1.17x
Moderate
Moderate leverage
Revenue Growth (YoY)
-9.2%
Shrinking
Sales are contracting
Profit Growth (YoY)
-210.2%
Falling
Profits are shrinking
Dividend Yield
None
None
No dividend yield reported — usually means no payout, but verify if one was recently initiated
Free Cash Flow
-₹112 Cr
Cash burning
Spending more cash than the operations bring in
More Metrics
CMP
₹43
Operating Margin
4.8%
Weak
Thin margins leave little room for error
Net Margin
-10.4%
Weak
Very little revenue reaches the bottom line
Current Ratio
1.50
Comfortable
Healthy short-term liquidity
52W Range Position
67%
Mid-range
Mid-range
Technical Snapshot
SMA 20 / SMA 50
47.0 / 36.0
Bullish alignment (short > long)
Price vs SMA 200
Above
Long-term uptrend
RSI (14)
27.8
Oversold zone
Financial Trend (2-Year)
Metric
FY25
FY26
1Y CAGR
Revenue
₹1,178 Cr
₹959 Cr
-18.6%
EBITDA
₹61 Cr
₹71 Cr
+15.0%
EBITDA Margin
5.2%
7.4%
—
PAT (Net Profit)
-₹32 Cr
-₹99 Cr
—
EPS
₹-0.65
₹-2.03
—
ROE
-3.5%
-12.4%
—
ROCE
4.7%
-0.7%
—
Total Debt
₹832 Cr
₹934 Cr
+12.3%
Free Cash Flow
-₹176 Cr
-₹112 Cr
—
🔴 Revenue has shrunk at 18.6% a year over 1 years.
🟢 EBITDA has grown at 15.0% a year over 1 years.
🟢 EBITDA Margin has risen from 5.2% to 7.4% over 1 years (+2.2 pts).
🔴 ROE has fallen from -3.5% to -12.4% over 1 years (-8.9 pts).
🔴 ROCE has fallen from 4.7% to -0.7% over 1 years (-5.4 pts).
🔴 Total Debt has grown at 12.3% a year over 1 years.
Revenue growth is negative (-9.2%) on the latest reported period — check if this is one-off or a trend.
Cross-check against the company's latest quarterly filing / investor presentation before acting.
RSI is in oversold territory — could mean either a bargain or a stock still falling for good reason. Check the 'why' before assuming reversal.
DalalBaazaar Thesis
🔴Business QualityWeak4.7/20
🔴Financial HealthStretched8.3/20
🔴GrowthWeak2.4/20
🔴ProfitabilityWeak2.5/15
🔴ValuationDemanding5.1/15
🔴RiskHigh2.4/10
Weak on the fundamentals
Poor scores on business quality without a price low enough to compensate. There is no obvious argument for owning this over a stronger company at a similar valuation. 3 high-severity red flags sit above this conclusion and should be read first.
